Chardan hires Gautam Chukka & Andreas Argyrides as Senior Equity Research Analysts on the Biotechnology team.

We’re excited to announce the hiring of Gautam Chukka and Andreas Argyrides, who join Chardan as senior equity research analysts.

Gautam and Andreas will lead coverage across the biotechnology sector, producing institutional-quality research on innovative companies at the forefront of life sciences. Their work will focus on identifying key trends, evaluating clinical and commercial developments, and delivering differentiated insights to investors across the healthcare landscape.

Both bring deep experience in equity research and a strong track record within biotechnology, further strengthening Chardan’s capabilities in the sector. Their addition underscores the firm’s continued commitment to expanding high-quality research coverage in areas of significant growth and innovation.